Inosine monophosphate dehydrogenase: a major therapeutic target
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
American Chemical Society
2003
|
| Schriftenreihe: | ACS symposium series
839 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | xiv, 352 p., [8] p. of plates ill. (some col.) : 24 cm |
| ISBN: | 0841237808 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV014807467 | ||
| 003 | DE-604 | ||
| 005 | 20030923 | ||
| 007 | t | ||
| 008 | 021015s2003 xxua||| |||| 10||| eng d | ||
| 010 | |a 2002035645 | ||
| 020 | |a 0841237808 |9 0-8412-3780-8 | ||
| 035 | |a (OCoLC)50773579 | ||
| 035 | |a (DE-599)BVBBV014807467 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-12 | ||
| 050 | 0 | |a QP603.I5 | |
| 082 | 0 | |a 615/.7 |2 21 | |
| 245 | 1 | 0 | |a Inosine monophosphate dehydrogenase |b a major therapeutic target |c Krzysztof W. Pankiewicz, Barry M. Goldstein, editors |
| 264 | 1 | |a Washington, D.C. |b American Chemical Society |c 2003 | |
| 300 | |a xiv, 352 p., [8] p. of plates |b ill. (some col.) : 24 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a ACS symposium series |v 839 | |
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a IMP déshydrogénase - Congrès | |
| 650 | 4 | |a IMP déshydrogénase - Inhibiteurs - Congrès | |
| 650 | 4 | |a Drug Design |v Congresses | |
| 650 | 4 | |a IMP Dehydrogenase |x antagonists & inhibitors |v Congresses | |
| 650 | 4 | |a IMP Dehydrogenase |x physiology |v Congresses | |
| 650 | 4 | |a IMP dehydrogenase |v Congresses | |
| 650 | 4 | |a IMP dehydrogenase |x Inhibitors |v Congresses | |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a IMP-Dehydrogenase |0 (DE-588)4758687-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2000 |z Washington DC |2 gnd-content | |
| 689 | 0 | 0 | |a IMP-Dehydrogenase |0 (DE-588)4758687-4 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Pankiewicz, Krzysztof W. |e Sonstige |4 oth | |
| 700 | 1 | |a Goldstein, Barry M. |e Sonstige |4 oth | |
| 830 | 0 | |a ACS symposium series |v 839 |w (DE-604)BV000003091 |9 839 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010019631&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-010019631 | ||
Datensatz im Suchindex
| _version_ | 1804129581004750848 |
|---|---|
| adam_text | INOSINE MONOPHOSPHATE DEHYDROGENASE STRUCTURE AND MECHANISM 7. IMPDH
STRUCTURE AND LIGAND BINDING 140 BARRY M. GOLDSTEIN, DIPESH RISAL, AND
MICHAEL STRICKLER 8. MONOVALENT CATION ACTIVATION OF IMP DEHYDROGENASE
169 GEORGE D. MARKHAM 9. IMP DEHYDROGENASE: MECHANISM OF DRUG
SELECTIVITY 184 LIZBETH HEDSTROM AND JENNIFER A. DIGITS 10. THE
DISCOVERY OF THIAZOLE-4-CARBOXAMIDE ADENINE DINUCLEOTIDE (TAD) AND A
RECENT SYNTHETIC APPROACH FOR THE CONSTRUCTION OF A HYDROLYTICALLY
RESISTANT SURROGATE 198 VICTOR E. MARQUEZ INHIBITOR DESIGN AND CLINICAL
APPLICATIONS 11. C-NUCLEOSIDE ANALOGS OF TIAZOFURIN AND SELENAZOFURIN AS
INOSINE 5 -MONOPHOSPHATE DEHYDROGENASE INHIBITORS 212 P. FRANCHETTI, L.
CAPPELLACCI, M. GRIFANTINI, H. N. JAYARAM, AND B. M. GOLDSTEIN 12.
STUDIES WITH BENZAMIDE RIBOSIDE, A RECENT INHIBITOR OF INOSINE
5 -MONOPHOSPHATE DEHYDROGENASE 231 HIREMAGALUR N. JAYARAM, JOEL A.
YALOWITZ, GEORG KRUPITZA, THOMAS SZEKERES, KARSTEN KROHN, AND KRZYSZTOF
W. PANKIEWICZ 13. COFACTOR ANALOGUES AS INHIBITORS OF IMP DEHYDROGENASE:
DESIGN AND NEW SYNTHETIC APPROACHES 247 KRZYSZTOF W. PANKIEWICZ, STEVEN
PATTERSON, HIREMAGALUR N. JAYARAM, AND BARRY M. GOLDSTEIN 14.
IDENTIFICATION OF SPECIFIC INHIBITORS OF IMP DEHYDROGENASE 282 FRANK R.
COLLART, AND ELIEZER HUBERMAN VLLL 15. MIZORIBINE: EXPERIMENTAL AND
CLINICAL EXPERIENCE 294 HIROAKI ISHIKAWA, MASAHIKO TSUCHIYA, AND
HIROMICHI ITOH INDEXES AUTHOR INDEX 331 SUBJECT INDEX 332 IX
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV014807467 |
| callnumber-first | Q - Science |
| callnumber-label | QP603 |
| callnumber-raw | QP603.I5 |
| callnumber-search | QP603.I5 |
| callnumber-sort | QP 3603 I5 |
| callnumber-subject | QP - Physiology |
| ctrlnum | (OCoLC)50773579 (DE-599)BVBBV014807467 |
| dewey-full | 615/.7 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.7 |
| dewey-search | 615/.7 |
| dewey-sort | 3615 17 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02137nam a2200517zcb4500</leader><controlfield tag="001">BV014807467</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20030923 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">021015s2003 xxua||| |||| 10||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2002035645</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0841237808</subfield><subfield code="9">0-8412-3780-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)50773579</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014807467</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP603.I5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.7</subfield><subfield code="2">21</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Inosine monophosphate dehydrogenase</subfield><subfield code="b">a major therapeutic target</subfield><subfield code="c">Krzysztof W. Pankiewicz, Barry M. Goldstein, editors</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">American Chemical Society</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 352 p., [8] p. of plates</subfield><subfield code="b">ill. (some col.) : 24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">ACS symposium series</subfield><subfield code="v">839</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IMP déshydrogénase - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IMP déshydrogénase - Inhibiteurs - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IMP Dehydrogenase</subfield><subfield code="x">antagonists & inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IMP Dehydrogenase</subfield><subfield code="x">physiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IMP dehydrogenase</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IMP dehydrogenase</subfield><subfield code="x">Inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">IMP-Dehydrogenase</subfield><subfield code="0">(DE-588)4758687-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2000</subfield><subfield code="z">Washington DC</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">IMP-Dehydrogenase</subfield><subfield code="0">(DE-588)4758687-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pankiewicz, Krzysztof W.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goldstein, Barry M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">ACS symposium series</subfield><subfield code="v">839</subfield><subfield code="w">(DE-604)BV000003091</subfield><subfield code="9">839</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010019631&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-010019631</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 2000 Washington DC gnd-content |
| genre_facet | Konferenzschrift 2000 Washington DC |
| id | DE-604.BV014807467 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:07:24Z |
| institution | BVB |
| isbn | 0841237808 |
| language | English |
| lccn | 2002035645 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-010019631 |
| oclc_num | 50773579 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | xiv, 352 p., [8] p. of plates ill. (some col.) : 24 cm |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | American Chemical Society |
| record_format | marc |
| series | ACS symposium series |
| series2 | ACS symposium series |
| spelling | Inosine monophosphate dehydrogenase a major therapeutic target Krzysztof W. Pankiewicz, Barry M. Goldstein, editors Washington, D.C. American Chemical Society 2003 xiv, 352 p., [8] p. of plates ill. (some col.) : 24 cm txt rdacontent n rdamedia nc rdacarrier ACS symposium series 839 Includes bibliographical references and index IMP déshydrogénase - Congrès IMP déshydrogénase - Inhibiteurs - Congrès Drug Design Congresses IMP Dehydrogenase antagonists & inhibitors Congresses IMP Dehydrogenase physiology Congresses IMP dehydrogenase Congresses IMP dehydrogenase Inhibitors Congresses Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf IMP-Dehydrogenase (DE-588)4758687-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2000 Washington DC gnd-content IMP-Dehydrogenase (DE-588)4758687-4 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Pankiewicz, Krzysztof W. Sonstige oth Goldstein, Barry M. Sonstige oth ACS symposium series 839 (DE-604)BV000003091 839 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010019631&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Inosine monophosphate dehydrogenase a major therapeutic target ACS symposium series IMP déshydrogénase - Congrès IMP déshydrogénase - Inhibiteurs - Congrès Drug Design Congresses IMP Dehydrogenase antagonists & inhibitors Congresses IMP Dehydrogenase physiology Congresses IMP dehydrogenase Congresses IMP dehydrogenase Inhibitors Congresses Pharmakotherapie (DE-588)4076066-2 gnd IMP-Dehydrogenase (DE-588)4758687-4 gnd |
| subject_GND | (DE-588)4076066-2 (DE-588)4758687-4 (DE-588)1071861417 |
| title | Inosine monophosphate dehydrogenase a major therapeutic target |
| title_auth | Inosine monophosphate dehydrogenase a major therapeutic target |
| title_exact_search | Inosine monophosphate dehydrogenase a major therapeutic target |
| title_full | Inosine monophosphate dehydrogenase a major therapeutic target Krzysztof W. Pankiewicz, Barry M. Goldstein, editors |
| title_fullStr | Inosine monophosphate dehydrogenase a major therapeutic target Krzysztof W. Pankiewicz, Barry M. Goldstein, editors |
| title_full_unstemmed | Inosine monophosphate dehydrogenase a major therapeutic target Krzysztof W. Pankiewicz, Barry M. Goldstein, editors |
| title_short | Inosine monophosphate dehydrogenase |
| title_sort | inosine monophosphate dehydrogenase a major therapeutic target |
| title_sub | a major therapeutic target |
| topic | IMP déshydrogénase - Congrès IMP déshydrogénase - Inhibiteurs - Congrès Drug Design Congresses IMP Dehydrogenase antagonists & inhibitors Congresses IMP Dehydrogenase physiology Congresses IMP dehydrogenase Congresses IMP dehydrogenase Inhibitors Congresses Pharmakotherapie (DE-588)4076066-2 gnd IMP-Dehydrogenase (DE-588)4758687-4 gnd |
| topic_facet | IMP déshydrogénase - Congrès IMP déshydrogénase - Inhibiteurs - Congrès Drug Design Congresses IMP Dehydrogenase antagonists & inhibitors Congresses IMP Dehydrogenase physiology Congresses IMP dehydrogenase Congresses IMP dehydrogenase Inhibitors Congresses Pharmakotherapie IMP-Dehydrogenase Konferenzschrift 2000 Washington DC |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010019631&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000003091 |
| work_keys_str_mv | AT pankiewiczkrzysztofw inosinemonophosphatedehydrogenaseamajortherapeutictarget AT goldsteinbarrym inosinemonophosphatedehydrogenaseamajortherapeutictarget |